Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2023 Filed Apr 25, 2023 20:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 10,224 | $35.00 | $357,840.00 |
DisclosureSEC source: 0001628280-23-012986 · wf-form4_168245631250830.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 20:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 10,224 | $0.91 | $9,303.84 |
DisclosureSEC source: 0001628280-23-012986 · wf-form4_168245631250830.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,296 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-012986 · wf-form4_168245631250830.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694,932 Underlying: Common Stock · 37,296 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 37,296 | $35.01 | $1,305,732.96 |
DisclosureSEC source: 0001628280-23-012986 · wf-form4_168245631250830.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 37,296 | $0.91 | $33,939.36 |
DisclosureSEC source: 0001628280-23-012986 · wf-form4_168245631250830.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 22:26 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 2,681 | $32.12 | $86,113.72 |
DisclosureSEC source: 0001628280-23-010905 · wf-form4_168073359079570.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,487 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,666 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,228 Underlying: Common Stock · 41,666 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 41,666 | $36.26 | $1,510,809.16 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,168 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.79 to $36.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,666 | $0.91 | $37,916.06 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 773,894 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 327 | $37.78 | $12,354.06 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,168 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.72 to $37.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,544 | $36.68 | $276,713.92 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,495 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.51 to $37.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 33,796 | $35.97 | $1,215,642.12 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,039 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.49 to $36.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-23-006539 · wf-form4_167813854802998.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 815,561 Underlying: Common Stock · 41,667 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,253 | $38.46 | $86,650.38 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,168 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.42 to $38.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 27,107 | $37.98 | $1,029,523.86 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,421 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.41 to $38.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,307 | $36.90 | $454,128.30 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,528 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.40 to $37.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 41,667 | $0.91 | $37,916.97 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 67,891 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,228 Underlying: Common Stock · 67,891 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 38,013 | $37.26 | $1,416,364.38 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,168 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.02 to $37.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20,347 | $36.75 | $747,752.25 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,181 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.015 to $37.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 9,531 | $35.42 | $337,588.02 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,528 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 21:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 67,891 | $0.91 | $61,780.81 |
DisclosureSEC source: 0001628280-23-006068 · wf-form4_167779311213382.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,824 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002774 · wf-form4_167589120025149.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,119 Underlying: Common Stock · 5,824 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,824 | $35.26 | $205,354.24 |
DisclosureSEC source: 0001628280-23-002774 · wf-form4_167589120025149.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,168 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 5,824 | $0.91 | $5,299.84 |
DisclosureSEC source: 0001628280-23-002774 · wf-form4_167589120025149.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 930,943 Underlying: Common Stock · 100,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,356 | $36.14 | $193,565.84 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,168 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $36.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 94,644 | $35.51 | $3,360,808.44 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,524 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.04 to $36.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 100,000 | $0.91 | $91,000.00 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030,943 Underlying: Common Stock · 100,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested and exercisable. F7 · balance_after: The amount reported in Column 9 of Table II reflects the Reporting Person's stock option exercise of 1,452 options, which were previously inadvertently omitted, as disclosed in the Reporting Person's Form 4/A filed on February 6, 2023. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 38,952 | $36.79 | $1,433,044.08 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,168 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.47 to $37.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 61,048 | $36.12 | $2,205,053.76 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,120 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.46 to $36.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:02 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 100,000 | $0.91 | $91,000.00 |
DisclosureSEC source: 0001628280-23-002437 · wf-form4_167572092159618.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132,395 Underlying: Common Stock · 100,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 100,000 | $35.18 | $3,518,000.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,716 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 100,000 | $0.91 | $91,000.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,285 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,232,395 Underlying: Common Stock · 1,285 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,285 | $35.00 | $44,975.00 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,716 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,285 | $0.91 | $1,169.35 |
DisclosureSEC source: 0001628280-23-002053 · wf-form4_167537292875614.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:17 UTC | Progyny, Inc. PGNY · Entity 4521 | Tax withholdingCommon Stock | 7,832 | $31.15 | $243,966.80 |
DisclosureSEC source: 0001628280-23-000456 · wf-form4_167295343834763.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,716 F1 · kind: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,146 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-029211 · wf-form4_166802776471943.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233,680 Underlying: Common Stock · 8,146 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 50 | $41.34 | $2,067.00 |
DisclosureSEC source: 0001628280-22-029211 · wf-form4_166802776471943.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 5,024 | $40.63 | $204,125.12 |
DisclosureSEC source: 0001628280-22-029211 · wf-form4_166802776471943.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,598 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $41.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,072 | $39.87 | $122,480.64 |
DisclosureSEC source: 0001628280-22-029211 · wf-form4_166802776471943.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,622 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.28 to $40.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 21:03 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 8,146 | $0.91 | $7,412.86 |
DisclosureSEC source: 0001628280-22-029211 · wf-form4_166802776471943.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,020 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001628280-22-028641 · wf-form4_166785557641664.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,241,826 Underlying: Common Stock · 25,020 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 200 | $42.00 | $8,400.00 |
DisclosureSEC source: 0001628280-22-028641 · wf-form4_166785557641664.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,548 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 21:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 24,820 | $39.28 | $974,929.60 |
DisclosureSEC source: 0001628280-22-028641 · wf-form4_166785557641664.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,748 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.18 to $40.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.